Biological Sample Collection Kits Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Biological Sample Collection Kits Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032


Global Biological Sample Collection Kits Market will experience an 8.8% CAGR between 2024 and 2032, due to advances in healthcare and diagnostics, underscoring the importance of precise and efficient sample collection. The rising prevalence of chronic diseases and the push for personalized medicine amplify this demand, necessitating more frequent and accurate sampling for effective patient management. For example, in March 2023, Cue Health unveiled a suite of home-use diagnostic test kits. These kits, emphasizing reliability and accuracy, empower users to manage their health through a safe, straightforward, and confidential sample collection process.

Moreover, technological innovations in kit design and functionality, alongside increasing investments in healthcare, are boosting the efficiency and accessibility of biological sample collection, driving the market's expansion.

The industry categorizes itself based on product type, application, end-use, and geographical region.

During the study period, the viral transport media segment is set to gain notable traction, primarily due to the heightened focus on swift and precise diagnostics. With global health systems prioritizing enhanced disease surveillance and response, especially for infectious outbreaks, there's a pronounced demand for dependable sample preservation and transportation. This demand is further amplified by strengthened public health protocols and an intensified emphasis on viral research and epidemiological studies, leading to broader adoption in diagnostic labs and healthcare settings.

By 2032, the research segment is expected to command a significant share of the biological sample collection kits market, driven by a surge in demand for specialized collection solutions. With increased funding and attention on biomedical research areas like genomics, proteomics, and infectious diseases, there's a pressing need for advanced sample collection kits to uphold research integrity and accuracy. As research institutions chase groundbreaking discoveries, the demand for dependable and efficient sample collection methods intensifies, propelling market growth.

Europe biological sample collection kits market is set for robust growth through 2032, fueled by a strong commitment to healthcare innovation and research. The rising incidence of chronic diseases and an emphasis on personalized medicine are driving the need for effective sample collection methods. Furthermore, Europe's stringent regulatory standards and emphasis on diagnostic accuracy necessitate advanced collection solutions. Coupled with investments in healthcare infrastructure and research funding, these factors are fostering the adoption of state-of-the-art technologies and enhancing the efficiency of sample collection processes.


Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of laboratory tests
3.2.1.2 Rising usage of lab tests for precise disease diagnosis
3.2.1.3 Growing R and D activities and technological advancements in sample collection techniques
3.2.1.4 Expansion of biobanking and personalized medicine
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of advanced kits and complexities associated with specimen collection
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Future market trends
3.7 Value chain analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Swabs
5.2.1 Nasopharyngeal (NP) swabs
5.2.2 Oropharyngeal (OP) swabs
5.2.3 Nasal swabs
5.3 Viral transport media
5.4 Blood collection kits
5.5 Urine collection kits
5.6 Other products
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Diagnostics
6.3 Research
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals and clinics
7.3 Diagnostic centers
7.4 Homecare
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Altona Diagnostics GmbH
9.3 Becton, Dickinson and Company
9.4 CTK Biotech, Inc.
9.5 F. Hoffmann-La Roche Ltd
9.6 Hardy Diagnostics
9.7 HiMedia Laboratories
9.8 Laboratory Corporation of America Holdings
9.9 Lucence Health Inc.
9.10 Medline Industries, Inc.
9.11 Miraclean Technology Co. Ltd
9.12 QIAGEN
9.13 Seegene Inc.
9.14 Thermo Fisher Scientific, Inc.
9.15 VIRCELL S.L.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings